Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol : the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Nyckelord

Adrenergic beta-Antagonists/*therapeutic use

Aged

Aged; 80 and over

Angiotensin II Type 1 Receptor Blockers/*therapeutic use

Antihypertensive Agents/therapeutic use

Atenolol/*therapeutic use

Blood Pressure/drug effects

Double-Blind Method

Female

Follow-Up Studies

Heart Rate/drug effects

Heart Ventricles/drug effects/pathology/ultrasonography

Humans

Hypertension/*complications/drug therapy

Hypertrophy; Left Ventricular/*drug therapy/etiology/ultrasonography

Losartan/*therapeutic use

Male

Middle Aged

Organ Size

Prospective Studies

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)